BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAE1. A total of 48 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $16,273,000 | +133.3% | 15,702,000 | +136.7% | 0.00% | +200.0% |
| Q2 2018 | $6,975,000 | -3.7% | 6,635,000 | -5.9% | 0.00% | -50.0% |
| Q1 2018 | $7,246,000 | -64.6% | 7,049,000 | -62.5% | 0.00% | -50.0% |
| Q4 2017 | $20,475,000 | +0.0% | 18,792,000 | +2.5% | 0.00% | -20.0% |
| Q3 2017 | $20,472,000 | +0.0% | 18,340,000 | -0.6% | 0.01% | 0.0% |
| Q2 2017 | $20,470,000 | +18.1% | 18,446,000 | +20.6% | 0.01% | +25.0% |
| Q1 2017 | $17,333,000 | -10.1% | 15,294,000 | -10.7% | 0.00% | -20.0% |
| Q4 2016 | $19,285,000 | -0.6% | 17,122,000 | +8.4% | 0.01% | 0.0% |
| Q3 2016 | $19,394,000 | +1.8% | 15,800,000 | -7.7% | 0.01% | 0.0% |
| Q2 2016 | $19,047,000 | -2.5% | 17,122,000 | +0.4% | 0.01% | 0.0% |
| Q1 2016 | $19,527,000 | +12.5% | 17,055,000 | +26.3% | 0.01% | +25.0% |
| Q4 2015 | $17,351,000 | +24.6% | 13,503,000 | +22.2% | 0.00% | 0.0% |
| Q3 2015 | $13,927,000 | -21.7% | 11,049,000 | -4.2% | 0.00% | 0.0% |
| Q2 2015 | $17,777,000 | +28.5% | 11,534,000 | +24.1% | 0.00% | +33.3% |
| Q1 2015 | $13,831,000 | -8.2% | 9,294,000 | -27.4% | 0.00% | 0.0% |
| Q4 2014 | $15,059,000 | +27.9% | 12,810,000 | +15.2% | 0.00% | 0.0% |
| Q3 2014 | $11,771,000 | -13.4% | 11,117,000 | -15.4% | 0.00% | 0.0% |
| Q2 2014 | $13,596,000 | -3.9% | 13,144,000 | +1.8% | 0.00% | -25.0% |
| Q1 2014 | $14,146,000 | +5.1% | 12,911,000 | +1.6% | 0.00% | 0.0% |
| Q4 2013 | $13,462,000 | – | 12,708,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|